Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-10-026339
Filing Date
2010-05-12
Accepted
2010-05-12 10:14:16
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v184541_10ka.htm 10-K/A 197512
2 v184541_ex10-149.htm EX-10.149 595958
3 GRAPHIC certainpatentrights.jpg GRAPHIC 93890
4 GRAPHIC developmentbudget.jpg GRAPHIC 227684
5 GRAPHIC relatedpartyshareholders.jpg GRAPHIC 215662
6 GRAPHIC schedule3aand5_pg01.jpg GRAPHIC 246296
7 GRAPHIC schedule3aand5_pg02.jpg GRAPHIC 70398
8 v184541_ex31-1.htm EX-31.1 6733
9 v184541_ex31-2.htm EX-31.2 6699
10 v184541_ex32-1.htm EX-32.1 7192
11 v184541_ex32-2.htm EX-32.2 7430
  Complete submission text file 0001144204-10-026339.txt   2000478
Mailing Address 13-01 POLLITT DRIVE FAIR LAWN NJ 07410
Business Address 1390 SOUTH 1100 EAST SUITE 204 SALT LAKE CITY UT 84105-2463 2017032299
Vyteris, Inc. (Filer) CIK: 0001139950 (see all company filings)

EIN.: 841394211 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-32741 | Film No.: 10822908
SIC: 2834 Pharmaceutical Preparations